Pneumococcal vaccine: when, what, how and to whom

F. Blasi (Milan, Italy)

Source: International Congress 2014 – MS06 What's new in pneumococcal vaccination?

Session: MS06 What's new in pneumococcal vaccination?
Session type: Morning Seminar
Number: 3172

Disease area: Respiratory infections

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
F. Blasi (Milan, Italy). Pneumococcal vaccine: when, what, how and to whom. International Congress 2014 – MS06 What's new in pneumococcal vaccination?

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Pneumococcal conjugate vaccine for adults: “It's tough to make predictions,…” Source: Eur Respir J 2015; 46: 1265-1268 Year: 2015
Pneumococcal vaccination: current and future issues Source: Eur Respir J 2001; 18: 184-195 Year: 2001
TB vaccination: why, when, how and what? Source: International Congress 2014 – PG20 Global evaluation of tuberculosis from children to adults Year: 2014
Pneumococcal vaccination in bronchiectasis- an area for improvement? Source: International Congress 2016 – Possible phenotypes of bronchiectasis and exacerbations Year: 2016
Pneumococcal and influenza vaccination Source: Respipedia Article Year: 2018
Clinical presentations and serotypes causing invasive pneumococcal disease in adults vaccinated with the 23-valent polysaccharide pneumococcal vaccine (PPV23) in Spain. The ODIN study (2010-2013) Source: International Congress 2014 – The epidemiology of respiratory infections and lung cancer Year: 2014
Development of RSV vaccines: where are we? Source: International Congress 2019 – Respiratory syncytial virus infections throughout life Year: 2019
Additive preventive effect of influenza and pneumococcal vaccines in elderly persons Source: Eur Respir J 2004; 23: 363-368 Year: 2004
Invasive pneumococcal disease (IPN) and pneumococcal vaccination in our setting Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management Year: 2015
The remaining challenges of pneumococcal disease in adults Source: Eur Respir Rev 2012; 21: 57-65 Year: 2012
Pneumococcal vaccination Source: Eur Respir J 2005; 26: 982-983 Year: 2005
COVID-19 vaccination and more Source: ERS webinar 2021: COVID-19 vaccination and more Year: 2021
Understanding new vaccines for SARS-CoV-2 and their regulation Source: ERS webinar 2021: Understanding new vaccines for SARS-CoV-2 and their regulation Year: 2021
Pneumococcal and influenza vaccination Source: Eur Respir Monogr 2014; 63: 266-284 Year: 2014
Influenza and pneumococcal immunization initiates work Source: Eur Respir J 2001; 18: Suppl. 33, 207s Year: 2001
Influenza: vaccination and treatment Source: Eur Respir J 2001; 17: 1282-1293 Year: 2001